Get introduced to the
most exciting companies in
our portfolio.

SyntheX

synthexlabs.com

Synthe X is revolutionizing drug discovery through its To R*FLEx* platform, which enables the identification of rare and selective drugs that target challenging proteins. By engineering cells to carry out drug discovery, Synthe X addresses the limitations of existing technologies, allowing access to previously inaccessible drug targets. The company focuses on novel mechanisms of action, particularly in oncology, and has established collaborations with major partners like Bristol Myers Squibb, showcasing its market position and traction in the biotech industry.